Biliary Tract Disease

• Audio chapter
  Single-voice audio, listen on the commute.
• ABIM-format MCQs
  5-option vignettes with full wrong-answer teaching.
• Study guide
  Tables, decision trees, primary sources.
• AI tutor
  Chapter-grounded, answers the question you're stuck on.

What this chapter covers

• Section 27.1: Cholelithiasis stone biology and risk factors

  Three stone phenotypes derive from three distinct biochemical environments.

• Section 27.2: Symptomatic cholelithiasis and indications for cholecystectomy

  Roughly 10 percent of US adults harbor stones and 75 percent are asymptomatic.

• Section 27.3: Acute cholecystitis Tokyo grading and treatment

  Persistent cystic duct obstruction by an impacted stone converts simple colic into acute cholecystitis: bile becomes increasingly concentrated, mucosal phospholipase liberates lysolecithin, and bacterial superinfection completes the picture with right-upper-quadrant pain, fever, leukocytosis, and a positive Murphy sign.

• Section 27.4: Acalculous cholecystitis and emphysematous variants

  Acalculous cholecystitis accounts for approximately 5 to 10 percent of acute cholecystitis but carries higher mortality (commonly cited at 30 to 50 percent in critically ill patients) for two mechanistic reasons: it occurs in fasting, often intubated trauma, surgical, burn, or septic patients where the diagnosis is delayed by sedation, paralysis, and competing diagnoses, and the pathogenesis (gallbladder ischemia from low-flow states with prolonged TPN, sepsis, or vasopressor exposure, plus cystic duct functional obstruction from inspissated bile) leads more rapidly to gangrenous wall progression than calculous disease.

• Section 27.5: Mirizzi syndrome and porcelain gallbladder

  Mirizzi syndrome (less than 1 percent of cholelithiasis complications) is extrinsic compression of the common hepatic duct by a stone impacted in the cystic duct or Hartmann's pouch at Calot's triangle, with chronic local inflammation that may progress to a cholecystocholedochal fistula.

• Section 27.6: Gallstone ileus and Bouveret syndrome

  A long-standing impacted gallstone with chronic inflammation can erode through the gallbladder wall into an adjacent hollow viscus, creating a cholecystenteric fistula (most often cholecystoduodenal, sometimes cholecystocolonic, gastric, or jejunal).

• Section 27.7: Gallbladder polyps and adenocarcinoma

  Gallbladder polyps are seen on approximately 5 percent of ultrasounds; 95 percent are benign.

• Section 27.8: Functional gallbladder disorder

  Rome IV criteria define functional gallbladder pain as biliary-type pain (epigastric or RUQ, at least 30 minutes long, severe enough to interrupt activities, not relieved by bowel movement, antacids, or postural change) in the absence of stones, sludge, microlithiasis, or other structural disease, with normal liver chemistries and normal lipase or amylase.

• Section 27.9: Choledocholithiasis and ASGE 2019 risk stratification

  Bile duct stones present with biliary colic plus more pronounced liver enzyme elevation, jaundice when obstruction is complete or prolonged, cholangitis when bacterial infection supervenes, and gallstone pancreatitis when the stone impacts at the ampulla.

• Section 27.10: Acute cholangitis and Tokyo Guidelines

  Cholangitis is ascending bacterial infection of an obstructed biliary tree, most commonly from choledocholithiasis but also from malignancy, anastomotic stricture, or stent occlusion.

• Section 27.11: Choledochal cysts and Caroli disease

  Todani classifies cystic dilations of the bile duct into five types that reflect anatomic location and dictate surgical strategy.

• Section 27.12: Bile leak and post-cholecystectomy stricture

  Bile leaks typically present within 10 days of cholecystectomy with abdominal pain or bile peritonitis, fever, leukocytosis, and elevated liver enzymes; persistent bilious drain output or biliary ascites confirms the diagnosis on imaging.

• Section 27.13: Sphincter of Oddi dysfunction (Rome IV)

  Sphincter of Oddi dysfunction is a non-calculous obstructive disorder at the level of the sphincter of Oddi caused by either passive obstruction from fibrosis or inflammation or active sphincter spasm; the two mechanisms are not mutually exclusive.

Podcast episodes

1. 01

   Gallstones and Acute Cholecystitis

   Episode one of the Biliary Tract Disease chapter starts with the stone, because the phenotype tells you what biochemical environment produced it, and that environment is really the risk-factor list seen from the mechanism side. Cholesterol stones come from supersaturation, dysmotility, or nucleation; black pigment stones from excess unconjugated bilirubin; brown pigment stones form new in the duct under stasis plus bacterial deconjugation. Asymptomatic stones are observed because the math favors it, unless a cancer or surgical-emergency configuration shifts the calculus, and true biliary colic tips a fit patient toward cholecystectomy. When persistent obstruction converts colic into acute cholecystitis, the Tokyo grade dictates how aggressively to operate, with the friable ischemic wall of the acalculous and emphysematous variants pushing drainage back toward the percutaneous route.

   Read the transcript →
2. 02

   Uncommon Gallbladder Presentations

   Episode two covers the less common gallbladder presentations, and the thread running through all of them is the same: chronic inflammatory remodeling around the gallbladder distorts the anatomy enough to change either the operation, the cancer risk, or the diagnostic frame. Stone-driven inflammation at Calot's triangle either compresses the bile duct from outside in Mirizzi, calcifies the wall in porcelain gallbladder, or erodes into bowel in gallstone ileus and Bouveret. The Csendes stage sets the reconstruction, the calcification pattern sets the cancer indication, and the level of stone impaction sets endoscopy versus surgery. Polyps test on a clean size rule with risk-factor modifiers, and functional gallbladder disorder tests on the discipline not to operate, because the failure mode is over-treating a heterogeneous category.

   Read the transcript →
3. 03

   Duct Stones and Acute Cholangitis

   Episode three takes the stone into the bile duct, and the whole problem sits on a probability question, because ERCP carries its own complication profile, headlined by post-ERCP pancreatitis. You earn the right to do an ERCP by raising the pretest probability of a retrievable stone high enough to justify the procedural risk, so high-probability patients go straight to ERCP while intermediate patients confirm the stone first with MRCP or endoscopic ultrasound. When the same stone turns septic, cholangitis runs on a hydraulic mechanism: the obstruction raises intraductal pressure and refluxes bacteria into the blood, which is why antibiotics alone cannot fix it and decompression is mandatory. The Tokyo grade scales the timing, and clinical improvement on antibiotics is never mistaken for a relieved obstruction.

   Read the transcript →
4. 04

   Cysts, Leaks, Strictures, and Sphincter Dysfunction

   Episode four turns to the duct that is structurally abnormal from birth or made abnormal by an operation, where the recurring move is to read the anatomy and let it dictate whether an endoscopic fix can work at all. Choledochal cysts drive cholangiocarcinoma through decades of epithelial exposure to refluxed enzymes, and the Todani type dictates the operation, with complete excision the rule and the choledochocele the low-risk exception. Bile leak and stricture are the iatrogenic version, where the Strasberg level decides whether endoscopic stenting can bridge the injury at all, so a cystic-stump leak seals with a stent while a complete transection needs hepaticojejunostomy. Sphincter of Oddi dysfunction divides into a true stenosis that sphincterotomy cures, a functional pain that a procedure only harms, and a heterogeneous middle where empiric sphincterotomy beats a manometry-driven workup.

   Read the transcript →

Key topics

• ·Cholesterol stones and the three lithogenic pathways
• ·Gallstone risk factors mapped to mechanism
• ·Black pigment stones and chronic hemolysis
• ·Brown pigment stones and the two-year rule
• ·Observation versus surgery for asymptomatic stones
• ·Prophylactic cholecystectomy indications
• ·Tokyo diagnosis and grading of cholecystitis
• ·Drainage options for the poor surgical candidate
• ·Acalculous and emphysematous variants
• ·Mirizzi syndrome and the Csendes classification
• ·MRCP staging and open conversion risk
• ·Porcelain gallbladder and calcification pattern
• ·Cholecystenteric fistula and gallstone ileus
• ·Bouveret syndrome and gastric outlet obstruction
• ·Gallbladder polyps and the size threshold
• ·Gallbladder adenocarcinoma biology
• ·Pancreaticobiliary maljunction
• ·Functional gallbladder disorder and over-treatment
• ·Post-ERCP pancreatitis and the probability tiers
• ·High, intermediate, and low probability features
• ·MRCP versus endoscopic ultrasound
• ·Large stones and post-cholecystectomy stones
• ·Cholangitis and the hydraulic mechanism
• ·Charcot triad and Reynolds pentad
• ·Tokyo grading and decompression timing
• ·Empiric antibiotics and rescue drainage
• ·Choledochal cysts and the Todani classification
• ·Cholangiocarcinoma risk and cyst anatomy
• ·Cyst excision and hepaticojejunostomy
• ·Caroli disease and syndrome